TY - JOUR
T1 - Enhancing Intrinsic Capacity and Related Biomarkers in Community-Dwelling Multimorbid Older Adults Through Integrated Multidomain Interventions
T2 - Ancillary Findings From the Taiwan Integrated Geriatric (TIGER) Trial
AU - Lee, Wei Ju
AU - Peng, Li Ning
AU - Lin, Ming Hsien
AU - Kim, Sunyoung
AU - Hsiao, Fei Yuan
AU - Chen, Liang Kung
N1 - Publisher Copyright:
© 2023 AMDA – The Society for Post-Acute and Long-Term Care Medicine
PY - 2024/5
Y1 - 2024/5
N2 - Objective: This study aimed to evaluate the efficacy of integrated multidomain interventions and primary health care on intrinsic capacity (IC) and related biomarkers. Design: An ancillary analysis from the Taiwan Integrated Geriatric Care (TIGER) study: a randomized controlled trial. Setting and Participants: A total of 398 community-dwelling older adults aged ≥65 years with ≥3 chronic conditions. Methods: Participants were randomized into the 12-month pragmatic multidomain intervention or usual care groups. The primary outcome was the change in IC and its subdomains (locomotion, cognition, vitality, psychological, and sensory) at baseline and 3-, 6-, 9-, and 12-month follow-ups. Generalized linear mixed models were used to evaluate the multidomain intervention effects on these changes. Results: The intervention arm had greater improvement in IC than the usual care arm (overall difference 1.5; 95% CI 0.5–2.5; P = .005), mainly from subdomains of locomotion (overall difference 1.4; 95% CI 0.5–2.4; P = .004) and cognition (2.9; 95% CI 2.1–3.7; P < .001). Changes in neutrophil-to-lymphocyte ratio (NLR −2.4; 95% CI −3.9 to −0.8, P = .003), serum levels of albumin (35.1; 95% CI 23.1–47.2; P < .001), dehydroepiandrosterone sulfate (DHEA-S 2.8; 95% CI 1.9–3.8; P < .001), free androgen index (FAI 1.5; 95% CI 1.1–1.9; P < .001), and vitamin D (4.0; 95% CI 2.0–6.1; P < .001) were associated with changes in IC over time. Conclusions and Implications: The incorporation of multidomain interventions into primary health care significantly enhanced IC over the 12-month program. Changes in NLR, FAI, and serum levels of albumin, DHEA-S, vitamin D were associated with changes in IC over time. Trial registration: ClinicalTrials.gov Identifier: NCT03528005.
AB - Objective: This study aimed to evaluate the efficacy of integrated multidomain interventions and primary health care on intrinsic capacity (IC) and related biomarkers. Design: An ancillary analysis from the Taiwan Integrated Geriatric Care (TIGER) study: a randomized controlled trial. Setting and Participants: A total of 398 community-dwelling older adults aged ≥65 years with ≥3 chronic conditions. Methods: Participants were randomized into the 12-month pragmatic multidomain intervention or usual care groups. The primary outcome was the change in IC and its subdomains (locomotion, cognition, vitality, psychological, and sensory) at baseline and 3-, 6-, 9-, and 12-month follow-ups. Generalized linear mixed models were used to evaluate the multidomain intervention effects on these changes. Results: The intervention arm had greater improvement in IC than the usual care arm (overall difference 1.5; 95% CI 0.5–2.5; P = .005), mainly from subdomains of locomotion (overall difference 1.4; 95% CI 0.5–2.4; P = .004) and cognition (2.9; 95% CI 2.1–3.7; P < .001). Changes in neutrophil-to-lymphocyte ratio (NLR −2.4; 95% CI −3.9 to −0.8, P = .003), serum levels of albumin (35.1; 95% CI 23.1–47.2; P < .001), dehydroepiandrosterone sulfate (DHEA-S 2.8; 95% CI 1.9–3.8; P < .001), free androgen index (FAI 1.5; 95% CI 1.1–1.9; P < .001), and vitamin D (4.0; 95% CI 2.0–6.1; P < .001) were associated with changes in IC over time. Conclusions and Implications: The incorporation of multidomain interventions into primary health care significantly enhanced IC over the 12-month program. Changes in NLR, FAI, and serum levels of albumin, DHEA-S, vitamin D were associated with changes in IC over time. Trial registration: ClinicalTrials.gov Identifier: NCT03528005.
KW - Multidomain interventions
KW - biomarkers
KW - integrated geriatric care
KW - intrinsic capacity
UR - http://www.scopus.com/inward/record.url?scp=85177834738&partnerID=8YFLogxK
U2 - 10.1016/j.jamda.2023.10.006
DO - 10.1016/j.jamda.2023.10.006
M3 - Article
C2 - 37949432
AN - SCOPUS:85177834738
SN - 1525-8610
VL - 25
SP - 757-763.e4
JO - Journal of the American Medical Directors Association
JF - Journal of the American Medical Directors Association
IS - 5
ER -